MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions
View by Date

Wednesday, September 25, 2019

1:15pm-2:45pm
Executive functions correlate with DaT-SPECT laterality in Parkinson’s disease

T. Alvarez-Avellon, E. Suarez-San Martin, C. Garcia-Fernandez, J. Alvarez-Carriles, R. Ribacoba, F. Cuetos, M. Menendez-Gonzalez (Oviedo, Spain)

Cognition and Cognitive Disorders  ·  Agora 3 East, Level 3
1:15pm-2:45pm
Expenditures on pesticides and incidence of Parkinson’s disease in French farmers: a nationwide study

L. Perrin, J. Spinosi, L. Chaperon, S. Kab, F. Moisan, A. Elbaz (Villejuif Cedex, France)

Epidemiology  ·  Les Muses, Level 3
1:15pm-2:45pm
Experimental model of developing of Parkinson’s disease

M. Tukhtamishev, F. Akhmedova (Tashkent, Uzbekistan)

Physiology and Pathophysiology  ·  Les Muses, Level 3
1:15pm-2:45pm
Exploratory analysis of the relationship between pain and mood disturbances in Parkinson’s disease

C. Vila, A. Sparks, P. Imbriani, N. Caputi, L. Covington, T. Schirinzi, S. Natoli, A. Pisani, P. Ghosh (Washington, DC, USA)

Non-Motor Symptoms  ·  Agora 3 West, Level 3
1:15pm-2:45pm
Exploring the Lexicon of Fatigue in Parkinson Disease: A Qualitative Approach

S. Mantri, S. Albert, S. Kahl, M. Daeschler, E. Mamikonyan, C. Kopil, C. Marras, L. Chahine (Durham, NC, USA)

Non-Motor Symptoms  ·  Agora 3 West, Level 3
1:15pm-2:45pm
Exploring the relationship between motor and non-motor fluctuations in Parkinson’s disease: patient’s perspective, clinician’ s assessment and objective measures from a wearable device

A. Leake, A. de Angelis, M. Horne, D. Paviour, J. Coebergh, M. Edwards, F. Morgante, L. Ricciardi (London, United Kingdom)

Non-Motor Symptoms  ·  Agora 3 West, Level 3
1:15pm-2:45pm
Extracellular α-synuclein enters dopaminergic neurons by modulating flotillin-1-assisted DAT endocytosis

T. Hasegawa, J. Kobayashi, N. Sugeno, S. Yoshida, T. Akiyama, Y. Miki, M. Fukuda, M. Ezura, A. Kikuchi, T. Baba, A. Takeda, K. Wakabayashi, H. Okano, M. Aoki (Sendai, Japan)

Physiology and Pathophysiology  ·  Les Muses, Level 3
1:15pm-2:45pm
Extrastriatal dopaminergic and serotonergic pathways in Parkinson’s disease and in dementia with Lewy bodies: a 123I-FP-CIT study

A. Pilotto, F. Schianodicola, E. Premi, R. Grasso, R. Turrone, S. Gipponi, A. Scalvini, E. Cottini, B. Pagherà, V. Garibotto, MC. Rizzetti, L. Bonanni, B. Borroni, S. Morbelli, F. Nobili, UP. Guerra, D. Perani, A. Padovani (Brescia, Italy)

Neuroimaging  ·  Les Muses Terrace, Level 3
1:15pm-2:45pm
Fatigue in Parkinson’s Disease

D. Silva, TR. Alcântara-Silva, AL. Alcântara-Silva, S. Suzuki-Godoy (Goiânia, Brazil)

Non-Motor Symptoms  ·  Agora 3 West, Level 3
1:15pm-2:45pm
Fatigue in Parkinson’s disease and its relation with disease duration and treatment

D. Nassif, J. Pereira (Rio de Janeiro, Brazil)

Non-Motor Symptoms  ·  Agora 3 West, Level 3
  • «Previous Page
  • 1
  • …
  • 22
  • 23
  • 24
  • 25
  • 26
  • …
  • 67
  • Next Page»

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley